Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy

QR Code

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy

© 2017 Elsevier Inc. Cancer is an extremely complex disease comprising of a multitude of characteristic hallmarks that continue to evolve with time. At the genomic level, random mutations leading to deregulation of diverse oncogenic signal transduction cascades and polymorphisms coupled with environ...

Full description

Bibliographic Details
Main Authors:	Min-Wen, J., Yan-Jiang, B., Mishra, S., Dai, X., Magae, J., Shyh-Chang, N., Kumar, Alan Prem, Sethi, G.
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/62609

Similar Items

Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
by: Dai, X., et al.
Published: (2015)

Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)

Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
by: Shanmugam, M., et al.
Published: (2013)

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
by: Shanmugam, M., et al.
Published: (2014)

Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

Possible use of Punica granatum (Pomegranate) in cancer therapy
by: Khwairakpam, A., et al.
Published: (2018)

Molecular targets modulated by fangchinoline in tumor cells and preclinical models
by: Mérarchi, M., et al.
Published: (2018)

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)

The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)

SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma
by: Sethi, G., et al.
Published: (2017)

The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
by: Arora, L., et al.
Published: (2018)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
by: Shrimali, D., et al.
Published: (2013)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Identification of novel peroxisome proliferator-activated receptor-gamma (PPAR[gamma]) agonists using molecular modeling method
by: Kumar, Alan Prem
Published: (2014)

Molecularly targeted therapies for asthma: current development, challenges and potential clinical translation
by: Sulaiman, Ibrahim, et al.
Published: (2016)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-ÎºB in hepatocellular carcinoma cells
by: Mohan, C., et al.
Published: (2018)

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy
by: Hay, Jodie F., et al.
Published: (2017)

Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma
by: Sikka, S., et al.
Published: (2014)

Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
by: Abbhi, V., et al.
Published: (2017)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)

Magnetic targeting of stem cell therapies
by: Harrison, Richard P.
Published: (2016)

Delineating the plausible molecular vaccine candidates and drug targets of multidrug-resistant Acinetobacter baumannii
by: Mujawar, Shama *, et al.
Published: (2019)

The future of osteoarthritis therapeutics: targeted pharmacological therapy
by: Mobasheri, Ali
Published: (2013)

Targeting DNA repair for personalisation of glioblastoma therapy
by: Perry, Christina Joy
Published: (2016)

Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-y
by: Bharathkumar, H., et al.
Published: (2014)

The potential role of boswellic acids in cancer prevention and treatment
by: Roy, N., et al.
Published: (2016)

Development of a novel azaspirane that targets the Janus Kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo
by: Mohan, C., et al.
Published: (2014)

PPARγ disease gene network and identification of therapeutic targets for prostate cancer
by: Venkatachalam, G., et al.
Published: (2011)

Targeted Stimulation of Micropores by CS2 Extraction on Molecular of Coal
by: Zhang, Zhen, et al.
Published: (2024)

DNA repair in cancer: emerging targets for personalized therapy
by: Abbotts, Rachel, et al.
Published: (2014)

Novel oral targeted therapies in inflammatory bowel disease
by: White, Jonathan Richard, et al.
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_70pkj2955ig33mkpsh1rgj92so